GLP
GLP3-RT
GIP/GLP-1/Glucagon Triple Receptor Agonist — Retatrutide
$119Retatrutide is a first-in-class triple hormone receptor agonist that engages GIP, GLP-1, and glucagon receptors simultaneously. Built on a modified GIP backbone, it represents the most advanced multi-agonist peptide in metabolic research, targeting three distinct but complementary signaling pathways.
Triple Receptor Agonism
Unique mechanism engaging GIP, GLP-1, and glucagon receptors simultaneously for comprehensive metabolic axis research.
Glucagon Receptor Component
Addition of glucagon receptor agonism enables study of hepatic energy expenditure and lipid metabolism pathways.
Next-Generation Design
Represents an evolution beyond dual-agonist designs, incorporating three incretin/glucagon receptor signaling pathways.
Retatrutide: A triple incretin receptor agonist for metabolic research
First major characterization of retatrutide's triple-agonist pharmacology and preclinical metabolic research data.
| Product Name | GLP3-RT (Retatrutide) |
| CAS Number | 2381089-83-2 |
| Molecular Formula | C₂₀₉H₃₁₈N₅₄O₆₃ |
| Molecular Weight | 4612.30 Da |
| Purity | ≥99% (HPLC) |
| Physical Form | White Lyophilized Powder |
| Storage | -20°C, protected from light |
| Certification | Third-party HPLC & MS verified |
| Intended Use | Research and laboratory use only |
